Tavipek

Tavipec refers to the pharmacotherapeutic group of drugs acting on the respiratory system and having expectorant properties. Tavipek belongs to the group of medicines that are used for cough and colds. The drug can be used as an adjuvant, in combination with other medications to treat such problems.

Indications Tavipek

Indications for the use of the drug Tavipek is considered to be the presence of symptoms of upper and lower respiratory tract diseases in the patient, which are accompanied by a cough - sinusitis, acute, chronic and emphysatous bronchitis, laryngorhitis, bronchiolitis, bronchiectasis (as an auxiliary therapy), emphysema of the lungs, smoker's cough, bronchial asthma, pulmonary tuberculosis.

The drug is used as one of the means of complex treatment of the above diseases.

Release form

Form release - the drug is produced in soft capsules, soluble in the intestine, one hundred and fifty mg of the drug in each.

Capsules are produced in a transparent, gelatin-coated shell; have an oval shape, yellow color, as well as a noticeable seam. Inside each capsule contains a movable transparent unpainted liquid. The liquid within the capsule can also be light yellow (some producers have a greenish-yellow color). The contents of the capsule have a scent of lavender.

One capsule contains:

• active substance - spicy lavender oil - one hundred and fifty mg;
• auxiliary substances: the shell of the capsule consists of components - gelatin, glycerin, yellow-orange colorant (E 110), quinoline yellow (E 104);
• auxiliary substances: acid-resistant coating of the capsule shell consists of components - eudragit, sodium lauryl sulfate, methacrylate copolymer (type A), propylene glycol, polysorbate 80, glycerol monostearate ..

The drug is issued in a cardboard box containing contour cells, ten capsules in each plate. In addition, the package contains instructions for using the drug.

The preparation is produced in a quantity of thirty pieces in each carton.

Pharmacodynamics

Pharmacodynamics of Tavipek drug is as follows:

• The drug is characterized by secretolitic, expectorant, mucolytic, epithelizing, anti-inflammatory, antimicrobial and immunostimulating properties.
• The secretolytic, mucolytic and expectorant effect is due to the properties of the active component of the spicy lavender oil. Due to the use of this drug, sputum is evacuated from the upper and lower respiratory tract with increased mucociliary clearance. As a result, mucus present in the respiratory tract is diluted, and the frequency of ciliary oscillation of the epithelium of the bronchial mucosa increases. All of the above contributes to a better release from excessive sputum in the respiratory tract and cessation of coughing.
• Epithelizing qualities of the drug consists in increasing the level of self-cleaning of the epithelium of the bronchi.
• Antimicrobial and anti-inflammatory effect of the drug was made possible due to the presence in the spiked oil of lavender properties that increase the activity of leukocytes. The use of Tavipek has a beneficial effect on the increase in phagocytic activity of leukocytes, which increases the immune properties of the patient's body, and also stimulates the antimicrobial and anti-inflammatory functioning of the cells of the immune system. The main component of lavender oil helps to reduce the activity of bacterial toxins: in staphylococci - alpha-hemolysin, in streptococci - streptolysin, and also helps to remove these substances from the body. The impact of the components of the spicy lavender oil makes it possible to suppress the development of most bacteria and fungi in the body (which include mycobacteria tuberculosis). At the same time, there is no disturbance of the intestinal microflora of the patient, which has a beneficial effect on improving the immunity and quality of fighting the symptoms of the disease.
• Immunostimulating effect of the drug is due to the effect of the active components of the preparation on cellular immunity and the increase in the activity of immune cells. This process involves an increase in the phagocytic function of white blood cells - leukocytes.

Pharmacokinetics

Pharmacokinetics of Tavipek drug is manifested in the following:

• The active component of the preparation is 1,8-cineol, which is labeled with an atom of ethereal lavender oil.
• The main component of spiked lavender oil - cineole - is absorbed by ninety-two percent into the walls of the gastrointestinal tract.
• The maximum content of active constituent spicy lavender oil in blood plasma is observed after two and a half hours.
• The level of bioavailability of the drug after the maximum residence time in the gastrointestinal tract does not decrease.
• The greatest amount of cineol in the blood plasma is 72.4 ng / ml.
• The half-life of the drug from the body is a time interval of one and a half hours.

Dosing and administration

Dosing and Administration of Tavipec:

• Adults are shown to take inwards one to two capsules of the drug three times a day.
• Children under the age of twelve are recommended to use one capsule three times a day.
• Capsules must be swallowed whole, with enough water, with the exception of chewing the drug.
• The drug is taken thirty minutes before meals.
• The maximum one-time use of the drug is two capsules.
• The maximum daily use of the drug is six capsules.
• The duration of treatment depends on the individual characteristics of the patient, the severity of the disease and the nature of the disease. Before taking the medication it is necessary to consult a specialist who determines the duration of use of Tavipec.

[3]

Use Tavipek during pregnancy

Use of the drug Tavipek during pregnancy is not provided. It is recommended to refrain from taking medication for this period, and also during lactation.

Contraindications

Contraindications to the use of Tavipek are as follows:

• The presence of hypersensitivity to any of the substances of the drug.
• Pregnancy and lactation in women.
• The drug is not used in children and adolescence until the age of twelve.
• The drug is not recommended for use with peptic ulcer, hyperacid gastritis, acute hepatitis, pancreatitis and nephritis.

[1]

Side effects Tavipek

If you use Tavipek according to the instructions, then side effects are usually not observed.

The following side effects of Tavipek drug have been identified:

• In rare cases, eructations may occur.
• Also, at some points after taking the drug, nausea may occur for a short period of time.
• There may be vomiting, as well as abdominal pain and dysgeusia.
• It is not excluded the development of allergic reactions to the effect of the drug. These include skin rashes, itching and redness of the skin.
• When you exhale after taking the medication for a certain amount of time, you can smell lavender oil, which is not accompanied by unpleasant sensations.
• The effect of the drug has not been noted, which affects the ability to drive vehicles or other mechanical means of transportation.

[2]

Overdose

Overdose with Tavipek is not known, as there is no information on cases of such use of the drug.

In medical practice there are no data on the symptoms of overdose with ethereal lavender oil.

Perhaps the appearance of nausea and some other gastrointestinal complaints, for example, heartburn.

Interactions with other drugs

The interaction of Tavipek with other drugs is not currently identified.

[4], [5]

Storage conditions

The storage conditions of Tavipek are as follows:

• It is recommended to store the drug at room temperature not exceeding twenty-five degrees Celsius.
• The drug should be kept in a place closed from sunlight.
• Tavipek should be kept out of reach of children.

Shelf life

Shelf life of the drug Tavipek is three years from the date of preparation.

It is forbidden to use the medicinal product after the expiration date indicated on the package.